Winston Tan

Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer

Christophe Massard, Michael S. Gordon, Sunil Sharma et al. · Journal of Clinical Oncology · 2016 · 839 citations · Full text

Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer

Xiaoyi Huang, Tiezheng Yuan, Meihua Liang et al. · European Urology · 2014 · 693 citations · Full text

Prognostic Biomarkers, Urology, Oncology +10

Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement

Ronald C. Chen, R. Bryan Rumble, D.A. Loblaw et al. · Journal of Clinical Oncology · 2016 · 358 citations · Full text

A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

Aminah Jatoi, Neil M. Ellison, Patrick A. Burch et al. · Cancer · 2003 · 286 citations

Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma

Christina A. Von Roemeling, Laura A. Marlow, Johnny J. Wei et al. · Clinical Cancer Research · 2013 · 273 citations · Full text